Development and validation of a high-performance liquid chromatography–tandem mass spectrometry assay quantifying olaparib in human plasma

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers

Peter C.C. Fong, David S. Boss, Timothy A. Yap et al. · New England Journal of Medicine · 2009 · 3.6K citations · Full text

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

Jonathan A. Ledermann, Philipp Harter, Charlie Gourley et al. · New England Journal of Medicine · 2012 · 1.9K citations

Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in <i>BRCA</i> Carrier Ovarian Cancer Correlating With Platinum-Free Interval

Peter C.C. Fong, Timothy A. Yap, David S. Boss et al. · Journal of Clinical Oncology · 2010 · 984 citations · Full text

Base Excision Repair Is Impaired in Mammalian Cells Lacking Poly(ADP-ribose) Polymerase-1

Françoise Dantzer, Guadelupe de la Rubia, Josiane Ménissier‐de Murcia et al. · Biochemistry · 2000 · 492 citations

Liquid chromatography–tandem mass spectrometric assay for the PARP-1 inhibitor olaparib in combination with the nitrogen mustard melphalan in human plasma

Rolf W. Sparidans, Irene Martens, Liselot Valkenburg‐van Iersel et al. · Journal of Chromatography B · 2011 · 33 citations

Molecular Pharmacology, Pharmaceutical Science, Nitrogen Mustard Melphalan +12